StockNews.com Downgrades Haemonetics (NYSE:HAE) to Hold
Haemonetics (NYSE:HAE – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Several other research firms have also recently issued reports on HAE. Raymond James reiterated a “strong-buy” rating and issued a $115.00 price objective (down from $120.00) […]
Haemonetics (NYSE:HAE – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Several other research firms have also recently issued reports on HAE. Raymond James reiterated a “strong-buy” rating and issued a $115.00 price objective (down from $120.00) […]
